These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38625797)

  • 21. Generating Mouse Models Using CRISPR-Cas9-Mediated Genome Editing.
    Qin W; Kutny PM; Maser RS; Dion SL; Lamont JD; Zhang Y; Perry GA; Wang H
    Curr Protoc Mouse Biol; 2016 Mar; 6(1):39-66. PubMed ID: 26928663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes.
    Mashiko D; Young SA; Muto M; Kato H; Nozawa K; Ogawa M; Noda T; Kim YJ; Satouh Y; Fujihara Y; Ikawa M
    Dev Growth Differ; 2014 Jan; 56(1):122-9. PubMed ID: 24372541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome editing in
    Sinha T; Yazdani SS
    STAR Protoc; 2022 Sep; 3(3):101629. PubMed ID: 36042883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Analysis of Genome Editors Efficiency on a Model of Mice Zygotes Microinjection.
    Averina OA; Permyakov OA; Grigorieva OO; Starshin AS; Mazur AM; Prokhortchouk EB; Dontsova OA; Sergiev PV
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9.
    Zhang L; Jia R; Palange NJ; Satheka AC; Togo J; An Y; Humphrey M; Ban L; Ji Y; Jin H; Feng X; Zheng Y
    PLoS One; 2015; 10(3):e0120396. PubMed ID: 25803037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GONAD: A Novel CRISPR/Cas9 Genome Editing Method that Does Not Require Ex Vivo Handling of Embryos.
    Gurumurthy CB; Takahashi G; Wada K; Miura H; Sato M; Ohtsuka M
    Curr Protoc Hum Genet; 2016 Jan; 88():15.8.1-15.8.12. PubMed ID: 26724720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines.
    Deleuze V; Soler E; Andrieu-Soler C
    STAR Protoc; 2024 Jun; 5(2):103016. PubMed ID: 38640065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome editing with the donor plasmid equipped with synthetic crRNA-target sequence.
    Ishibashi R; Abe K; Ido N; Kitano S; Miyachi H; Toyoshima F
    Sci Rep; 2020 Aug; 10(1):14120. PubMed ID: 32839482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic mouse production by zygote injection.
    Conner DA
    Curr Protoc Mol Biol; 2004 Nov; Chapter 23():Unit 23.9. PubMed ID: 18265349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes.
    Yoshimi K; Kunihiro Y; Kaneko T; Nagahora H; Voigt B; Mashimo T
    Nat Commun; 2016 Jan; 7():10431. PubMed ID: 26786405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly Efficient Transgenesis in Ferrets Using CRISPR/Cas9-Mediated Homology-Independent Insertion at the ROSA26 Locus.
    Yu M; Sun X; Tyler SR; Liang B; Swatek AM; Lynch TJ; He N; Yuan F; Feng Z; Rotti PG; Choi SH; Shahin W; Liu X; Yan Z; Engelhardt JF
    Sci Rep; 2019 Feb; 9(1):1971. PubMed ID: 30760763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas9-mediated insertion of a short artificial intron for the generation of conditional alleles in mice.
    Cassidy A; Pelletier S
    STAR Protoc; 2023 Mar; 4(1):102116. PubMed ID: 36853660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient gene targeting in mouse zygotes mediated by CRISPR/Cas9-protein.
    Jung CJ; Zhang J; Trenchard E; Lloyd KC; West DB; Rosen B; de Jong PJ
    Transgenic Res; 2017 Apr; 26(2):263-277. PubMed ID: 27905063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
    Qin W; Wang H
    Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On-Target CRISPR/Cas9 Activity Can Cause Undesigned Large Deletion in Mouse Zygotes.
    Korablev A; Lukyanchikova V; Serova I; Battulin N
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-step CRISPR-Cas9 protocol for transposable element deletion in D. melanogaster natural populations.
    Merenciano M; Aguilera L; González J
    STAR Protoc; 2023 Sep; 4(3):102501. PubMed ID: 37590151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome Editing in Mice Using CRISPR/Cas9 Technology.
    Hall B; Cho A; Limaye A; Cho K; Khillan J; Kulkarni AB
    Curr Protoc Cell Biol; 2018 Dec; 81(1):e57. PubMed ID: 30178917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-Cas9-Mediated Genomic Deletions Protocol in Zebrafish.
    Amorim JP; Bordeira-Carriço R; Gali-Macedo A; Perrod C; Bessa J
    STAR Protoc; 2020 Dec; 1(3):100208. PubMed ID: 33377102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Optimized Preparation Method for Long ssDNA Donors to Facilitate Quick Knock-In Mouse Generation.
    Inoue YU; Morimoto Y; Yamada M; Kaneko R; Shimaoka K; Oki S; Hotta M; Asami J; Koike E; Hori K; Hoshino M; Imayoshi I; Inoue T
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.